| 12.89 BATS BZX Real-Time Price As of 2:49pm ET |  +0.30 / +2.38%Today’s Change | 3.80 Today|||52-Week Range 16.94 | +110.97% Year-to-Date |
| Previous close | 12.59 |
| Today’s open | 12.50 |
| Day’s range | 12.36 - 12.91 |
| Volume | 9,473 |
| Average volume (3 months) | 622,286 |
| Market cap | $812.3M |
| Earnings growth (last year) | +2.86% |
| Earnings growth (this year) | -16.60% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -6.72% |
| P/E ratio | NM |
| Price/Sales | 62.47 |
| Price/Book | 8.59 |
| Today’s change | Today’s % change | |
|---|---|---|
| IMGNImmunoGen Inc | +0.14 | +2.40% |
| DCPHDeciphera Pharmaceut... | -0.41 | -1.80% |
| QUREUniqure NV | +0.93 | +3.01% |
| NTLAIntellia Therapeutic... | +0.27 | +1.56% |
| Next reporting date | March 14, 2019 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $4.1M |
| Annual profit (last year) | -$43.0M |
| Net profit margin | -1,046.08% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director J. Scott Wolchko |
Chief Scientific Officer Daniel D. Shoemaker |
Corporate headquarters San Diego, California |
